다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Gut and liver, v.9 no.1, 2015년, pp.28 - 37
Freeman, Hugh J. (Department of Medicine, University of British Columbia, Vancouver, Canada)
AI-Helper
Celiac disease is a chronic genetically based gluten-sensitive immune-mediated enteropathic process primarily affecting the small intestinal mucosa. The disorder classically presents with diarrhea and weight loss; however, more recently, it has been characterized by subclinical occult or latent dise...
1 Freeman HJ Chopra A Clandinin MT Thomson AB Recent advances in celiac disease World J Gastroenterol 2011 17 2259 2272 10.3748/wjg.v17.i18.2259 3098394 --> 21633592
2 Gujral N Freeman HJ Thomson AB Celiac disease: prevalence, diagnosis, pathogenesis and treatment World J Gastroenterol 2012 18 6036 6059 10.3748/wjg.v18.i42.6036 3496881 --> 23155333
3 Freeman HJ Pearls and pitfalls in the diagnosis of adult celiac disease Can J Gastroenterol 2008 22 273 280 2662202 --> 18354756
4 Freeman HJ Neurological disorders in adult celiac disease Can J Gastroenterol 2008 22 909 911 2661192 --> 19018335
5 Freeman HJ Risk factors in familial forms of celiac disease World J Gastroenterol 2010 16 1828 1831 10.3748/wjg.v16.i15.1828 2856821 --> 20397258
6 Ivarsson A Persson LA Nyström L Epidemic of coeliac disease in Swedish children Acta Paediatr 2000 89 165 171 10.1111/j.1651-2227.2000.tb01210.x 10709885
7 Lebwohl B Ludvigsson JF Green PH The unfolding story of celiac disease risk factors Clin Gastroenterol Hepatol 2014 12 632 635 10.1016/j.cgh.2013.10.031 24211288
8 Freeman HJ Strongly positive tissue transglutaminase antibody assays without celiac disease Can J Gastroenterol 2004 18 25 28 14760428
9 Rubio-Tapia A Hill ID Kelly CP Calderwood AH Murray JA American College of Gastroenterology ACG clinical guidelines: diagnosis and management of celiac disease Am J Gastroenterol 2013 108 656 676 10.1038/ajg.2013.79 3706994 --> 23609613
10 Freeman HJ The Neolithic revolution and subsequent emergence of the celiac affection Int J Celiac Dis 2013 1 19 22
11 Lohi S Mustalahti K Kaukinen K Increasing prevalence of coeliac disease over time Aliment Pharmacol Ther 2007 26 1217 1225 10.1111/j.1365-2036.2007.03502.x 17944736
12 Dietrich O Heun M Notroff J Schmidt K Zarnkow M The role of cult and feasting in the emergence of Neolithic communities: new evidence from Gobekli Tepe, south-eastern Turkey Antiquity 2012 86 674 695
13 Heun M Schäfer-Pregl R Klawan D Site of Einkorn wheat domestication identified by DNA fingerprinting Science 1997 278 1312 1314 10.1126/science.278.5341.1312
14 Adams F On the coeliac affection: the extant works of Aretaeus, the Cappadocian London Sydenham Society 1856 350 351
15 Gasbarrini G Miele L Corazza GR Gasbarrini A When was celiac disease born? The Italian case from the archeologic site of Cosa J Clin Gastroenterol 2010 44 502 503 10.1097/MCG.0b013e3181d345a5 20631553
16 Gee SJ On the coeliac affection St Bartholomews Hosp Rep 1888 24 17 20
17 Haas SV The value of the banana in the treatment of celiac disease Am J Dig Child 1924 28 421 437
18 van Berge-Henegouwen GP Mulder CJ Pioneer in the gluten free diet: Willem-Karel Dicke 1905–1962, over 50 years of gluten free diet Gut 1993 34 1473 1475 10.1136/gut.34.11.1473 1374403 --> 8244125
19 Paulley JW Observation on the aetiology of idiopathic steatorrhoea: jejunal and lymph-node biopsies Br Med J 1954 2 1318 1321 10.1136/bmj.2.4900.1318 2080246 --> 13209109
20 Freeman HJ Non-dietary forms of treatment for adult celiac disease World J Gastrointest Pharmacol Ther 2013 4 108 112 3817285 --> 24199026
21 Freeman HJ Celiac disease associated with primary biliary cirrhosis in a Coast Salish native Can J Gastroenterol 1994 8 105 107
22 Suttles WP Coping with abundance: subsistence on the northwest coast Suttles WP Maud R Coast Salish essays Seattle University of Washington Press 1987 45 63
23 Freeman HJ Adult celiac disease and its malignant complications Gut Liver 2009 3 237 246 10.5009/gnl.2009.3.4.237 20431755
24 Weinstein WM Latent celiac sprue Gastroenterology 1974 66 489 493 4821074
25 Freeman HJ Chiu BK Multifocal small bowel lymphoma and latent celiac sprue Gastroenterology 1986 90 1992 1997 3699415
26 Freeman HJ Refractory celiac disease and sprue-like intestinal disease World J Gastroenterol 2008 14 828 830 10.3748/wjg.14.828 2687049 --> 18240339
27 Freeman HJ Sprue-like intestinal disease Int J Celiac Dis 2014 2 6 10
28 Ruemmele FM Müller T Schiefermeier N Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model Hum Mutat 2010 31 544 551 10.1002/humu.21224 20186687
29 Wiegerinck CL Janecke AR Schneeberger K Loss of syntaxin 3 causes variant microvillus inclusion disease Gastroenterology 2014 147 65 68 10.1053/j.gastro.2014.04.002 24726755
30 Gooding IR Springall R Talbot IC Silk DB Idiopathic small-intestinal inflammation after colectomy for ulcerative colitis Clin Gastroenterol Hepatol 2008 6 707 709 10.1016/j.cgh.2008.02.031 18467187
31 Rosenfeld GA Freeman H Brown M Steinbrecher UP Severe and extensive enteritis following colectomy for ulcerative colitis Can J Gastroenterol 2012 26 866 867 3551556 --> 23248782
32 Robinson JW Intestinal malabsorption in the experimental animal Gut 1972 13 938 945 10.1136/gut.13.11.938 1412416 --> 4566960
33 Freeman HJ Drug-induced sprue-like intestinal disease Int J Celiac Dis 2014 2 49 53
34 Freeman HJ Sulindac-associated small bowel lesion J Clin Gastroenterol 1986 8 569 571 10.1097/00004836-198610000-00017 2946757
35 Ziegler TR Fernández-Estívariz C Gu LH Fried MW Leader LM Severe villus atrophy and chronic malabsorption induced by azathioprine Gastroenterology 2003 124 1950 1957 10.1016/S0016-5085(03)00405-0 12806628
36 Ducloux D Ottignon Y Semhoun-Ducloux S Mycophenolate mofetil-induced villous atrophy Transplantation 1998 66 1115 1116 10.1097/00007890-199810270-00027 9808503
37 Kamar N Faure P Dupuis E Villous atrophy induced by mycophenolate mofetil in renal-transplant patients Transpl Int 2004 17 463 467 10.1111/j.1432-2277.2004.tb00471.x 15322747
38 Tapia O Villaseca M Sierralta A Roa JC Duodenal villous atrophy associated with Mycophenolate mofetil: report of one case Rev Med Chil 2010 138 590 594 20668815
39 Jacobson ED Prior JT Faloon WW Malabsorptive syndrome induced by neomyclin: morphologic alterations in the jejunal mucosa J Lab Clin Med 1960 56 245 250 14406406
40 Race TF Paes IC Faloon WW Intestinal malabsorption induced by oral colchicines: comparison with neomycin and cathartic agents Am J Med Sci 1970 259 32 41 10.1097/00000441-197001000-00005 5416781
41 Wright N Watson A Morley A Appleton D Marks J Douglas A The cell cycle time in the flat (avillous) mucosa of the human small intestine Gut 1973 14 603 606 10.1136/gut.14.8.603 1412748 --> 4270325
42 Trier JS Morphologic alterations induced by methotrexate in the mucosa of human proximal intestine. I. Serial observations by light microscopy Gastroenterology 1962 42 295 305 13922473
43 Rubio-Tapia A Herman ML Ludvigsson JF Severe spruelike enteropathy associated with olmesartan Mayo Clin Proc 2012 87 732 738 10.1016/j.mayocp.2012.06.003 3538487 --> 22728033
44 Gentile NM D’Souza A Fujii LL Wu TT Murray JA Association between ipilimumab and celiac disease Mayo Clin Proc 2013 88 414 417 10.1016/j.mayocp.2013.01.015 23541015
45 Cooke WT Holmes GK Definition and epidemiology Cooke WT Holmes GK Celiac disease Edinburgh Churchill Livingstone 1984 11 22
46 Mylotte M Egan-Mitchell B McCarthy CF McNicholl B Incidence of coeliac disease in the West of Ireland Br Med J 1973 1 703 705 10.1136/bmj.1.5855.703 1588876 --> 4694691
47 Kowlessar OD Phillips LD Celiac disease Med Clin North Am 1970 54 647 656 5423138
48 Fasano A Berti I Gerarduzzi T Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study Arch Intern Med 2003 163 286 292 10.1001/archinte.163.3.286 12578508
49 Mäki M Mustalahti K Kokkonen J Prevalence of Celiac disease among children in Finland N Engl J Med 2003 348 2517 2524 10.1056/NEJMoa021687 12815137
50 West J Logan RF Hill PG Seroprevalence, correlates, and characteristics of undetected coeliac disease in England Gut 2003 52 960 965 10.1136/gut.52.7.960 1773707 --> 12801951
51 Wong RC Wilson RJ Steele RH Radford-Smith G Adelstein S A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits J Clin Pathol 2002 55 488 494 10.1136/jcp.55.7.488 1769686 --> 12101191
52 Van Meensel B Hiele M Hoffman I Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease Clin Chem 2004 50 2125 2135 10.1373/clinchem.2004.035832 15388634
53 Punglia RS D’Amico AV Catalona WJ Roehl KA Kuntz KM Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen N Engl J Med 2003 349 335 342 10.1056/NEJMoa021659 12878740
54 Rewers M Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 2005 128 S47 S51 10.1053/j.gastro.2005.02.030 15825126
55 Cavell B Stenhammar L Ascher H Increasing incidence of childhood coeliac disease in Sweden: results of a national study Acta Paediatr 1992 81 589 592 10.1111/j.1651-2227.1992.tb12306.x 1392381
56 Carlsson AK Axelsson IE Borulf SK Bredberg AC Ivarsson SA Serological screening for celiac disease in healthy 2.5-year-old children in Sweden Pediatrics 2001 107 42 45 10.1542/peds.107.1.42 11134432
57 Catassi C Rätsch IM Fabiani E High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by anti-gliadin antibodies Acta Paediatr 1995 84 672 676 10.1111/j.1651-2227.1995.tb13725.x 7670254
58 Cook HB Burt MJ Collett JA Whitehead MR Frampton CM Chapman BA Adult coeliac disease: prevalence and clinical significance J Gastroenterol Hepatol 2000 15 1032 1036 10.1046/j.1440-1746.2000.02290.x 11059933
59 Hovell CJ Collett JA Vautier G High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening? Med J Aust 2001 175 247 250 11587254
60 Gomez JC Selvaggio GS Viola M Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area Am J Gastroenterol 2001 96 2700 2704 10.1111/j.1572-0241.2001.04124.x 11569698
61 Shamir R Lerner A Shinar E The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors Am J Gastroenterol 2002 97 2589 2594 10.1111/j.1572-0241.2002.06028.x 12385444
62 Hoffenberg EJ MacKenzie T Barriga KJ A prospective study of the incidence of childhood celiac disease J Pediatr 2003 143 308 314 10.1067/S0022-3476(03)00282-8 14517510
63 Catassi C Rätsch IM Gandolfi L Why is coeliac disease endemic in the people of the Sahara? Lancet 1999 354 647 648 10.1016/S0140-6736(99)02609-4 10466670
64 Rubio-Tapia A Kyle RA Kaplan EL Increased prevalence and mortality in undiagnosed celiac disease Gastroenterology 2009 137 88 93 10.1053/j.gastro.2009.03.059 2704247 --> 19362553
65 Catassi C Kryszak D Bhatti B Natural history of celiac disease autoimmunity in a USA cohort followed since 1974 Ann Med 2010 42 530 538 10.3109/07853890.2010.514285 20868314
66 Freeman HJ Detection of adult celiac disease with duodenal screening biopsies over a 30-year period Can J Gastroenterol 2013 27 405 408 3956015 --> 23862172
67 Namatovu F Sandström O Olsson C Lindkvist M Ivarsson A Celiac disease risk varies between birth cohorts, generating hypotheses about causality: evidence from 36 years of population-based follow-up BMC Gastroenterol 2014 14 59 10.1186/1471-230X-14-59 3977663 --> 24693975
68 West J Fleming KM Tata LJ Card TR Crooks CJ Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study Am J Gastroenterol 2014 109 757 768 10.1038/ajg.2014.55 4012300 --> 24667576
69 Jiang LL Zhang BL Liu YS Is adult celiac disease really uncommon in Chinese? J Zhejiang Univ Sci B 2009 10 168 171 10.1631/jzus.B0820164 2650025 --> 19283870
70 Gweon TG Lim CH Byeon SW A case of celiac disease Korean J Gastroenterol 2013 61 338 342 10.4166/kjg.2013.61.6.338 23877215
71 Freeman HJ Biopsy-defined adult celiac disease in Asian-Canadians Can J Gastroenterol 2003 17 433 436 12915916
72 Yuan J Gao J Li X The tip of the “celiac iceberg” in China: a systematic review and meta-analysis PLoS One 2013 8 e81151 10.1371/journal.pone.0081151 24324669
73 Stene LC Honeyman MC Hoffenberg EJ Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study Am J Gastroenterol 2006 101 2333 2340 10.1111/j.1572-0241.2006.00741.x 17032199
74 Riddle MS Murray JA Cash BD Pimentel M Porter CK Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study Dig Dis Sci 2013 58 3242 3245 10.1007/s10620-013-2733-7 23812827
75 Kondrashova A Mustalahti K Kaukinen K Lower economic status and inferior hygienic environment may protect against celiac disease Ann Med 2008 40 223 231 10.1080/07853890701678689 18382888
76 Szajewska H Chmielewska A Pieścik-Lech M Systematic review: early infant feeding and the prevention of coeliac disease Aliment Pharmacol Ther 2012 36 607 618 10.1111/apt.12023 22905651
77 Norris JM Barriga K Hoffenberg EJ Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease JAMA 2005 293 2343 2351 10.1001/jama.293.19.2343 15900004
78 Carroccio A Di Prima L Noto D Searching for wheat plants with low toxicity in celiac disease: between direct toxicity and immunologic activation Dig Liver Dis 2011 43 34 39 10.1016/j.dld.2010.05.005 20554485
79 Spaenij-Dekking L Kooy-Winkelaar Y van Veelen P Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients Gastroenterology 2005 129 797 806 10.1053/j.gastro.2005.06.017 16143119
80 Makharia GK Current and emerging therapy for celiac disease Front Med 2014 1 6 10.3389/fmed.2014.00006
81 Pinier M Verdu EF Nasser-Eddine M Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium Gastroenterology 2009 136 288 298 10.1053/j.gastro.2008.09.016 18992747
82 Pinier M Fuhrmann G Galipeau HJ The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues Gastroenterology 2012 142 316 325 10.1053/j.gastro.2011.10.038 22079593
83 Sollid LM Qiao SW Anderson RP Gianfrani C Koning F Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules Immunogenetics 2012 64 455 460 10.1007/s00251-012-0599-z 3349865 --> 22322673
84 Gass J Khosla C Prolyl endopeptidases Cell Mol Life Sci 2007 64 345 355 10.1007/s00018-006-6317-y 17160352
85 Garcia-Horsman JA Venäläinen JI Lohi O Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease Scand J Gastroenterol 2007 42 562 571 10.1080/00365520601019819 17454876
86 Piper JL Gray GM Khosla C High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue Biochemistry 2002 41 386 393 10.1021/bi011715x 11772038
87 Khosla C Gray GM Sollid LM Putative efficacy and dosage of prolyl endopeptidase for digesting and detoxifying gliadin peptides Gastroenterology 2005 129 1362 1363 10.1053/j.gastro.2005.08.044 16230098
88 Gass J Vora H Bethune MT Gray GM Khosla C Effect of barley endoprotease EP-B2 on gluten digestion in the intact rat J Pharmacol Exp Ther 2006 318 1178 1186 10.1124/jpet.106.104315 16757540
89 Stepniak D Spaenij-Dekking L Mitea C Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease Am J Physiol Gastrointest Liver Physiol 2006 291 G621 G629 10.1152/ajpgi.00034.2006 16690904
90 Mitea C Havenaar R Drijfhout JW Edens L Dekking L Koning F Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease Gut 2008 57 25 32 10.1136/gut.2006.111609 17494108
91 Siegel M Bethune MT Gass J Rational design of combination enzyme therapy for celiac sprue Chem Biol 2006 13 649 658 10.1016/j.chembiol.2006.04.009 16793522
92 Siegel M Garber ME Spencer AG Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials Dig Dis Sci 2012 57 440 450 10.1007/s10620-011-1906-5 21948339
93 Tye-Din JA Anderson RP Ffrench RA The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo Clin Immunol 2010 134 289 295 10.1016/j.clim.2009.11.001 19942485
94 Gass J Bethune MT Siegel M Spencer A Khosla C Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue Gastroenterology 2007 133 472 480 10.1053/j.gastro.2007.05.028 17681168
95 Lähdeaho ML Kaukinen K Laurila K Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease Gastroenterology 2014 146 1649 1658 10.1053/j.gastro.2014.02.031 24583059
96 Di Cagno R Barbato M Di Camillo C Gluten-free sourdough wheat baked goods appear safe for young celiac patients: a pilot study J Pediatr Gastroenterol Nutr 2010 51 777 783 10.1097/MPG.0b013e3181f22ba4 20975578
97 Greco L Gobbetti M Auricchio R Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing Clin Gastroenterol Hepatol 2011 9 24 29 10.1016/j.cgh.2010.09.025 20951830
98 De Angelis M Rizzello CG Fasano A VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue Biochim Biophys Acta 2006 1762 80 93 10.1016/j.bbadis.2005.09.008 16311022
99 Madsen K Cornish A Soper P Probiotic bacteria enhance murine and human intestinal epithelial barrier function Gastroenterology 2001 121 580 591 10.1053/gast.2001.27224 11522742
100 Fasano A Not T Wang W Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease Lancet 2000 355 1518 1519 10.1016/S0140-6736(00)02169-3 10801176
101 Lammers KM Lu R Brownley J Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3 Gastroenterology 2008 135 194 204 10.1053/j.gastro.2008.03.023 2653457 --> 18485912
102 Paterson BM Lammers KM Arrieta MC Fasano A Meddings JB The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study Aliment Pharmacol Ther 2007 26 757 766 10.1111/j.1365-2036.2007.03413.x 17697209
103 Kelly CP Green PH Murray JA Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study Aliment Pharmacol Ther 2013 37 252 262 10.1111/apt.12147 23163616
104 Molberg O McAdam S Lundin KE T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase Eur J Immunol 2001 31 1317 1323 10.1002/1521-4141(200105)31:5 3.0.CO;2-I 11465088
105 Maiuri L Ciacci C Ricciardelli I Unexpected role of surface transglutaminase type II in celiac disease Gastroenterology 2005 129 1400 1413 10.1053/j.gastro.2005.07.054 16285941
106 Silano M Vincentini O Iapello A Mancini E De Vincenzi M Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease J Clin Gastroenterol 2008 42 Suppl 3 Pt 2 S191 S192 10.1097/MCG.0b013e31817df76a 18685513
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.